BofA lowered the firm’s price target on DocuSign to $68 from $72 and keeps a Neutral rating on the shares after the company reported "mixed" Q4 results and gave guidance for FY24 revenue and billings below the firm’s estimates. The outlook for 2% billings growth reflects significant disruption from the move to self-service and two reductions in force, but "the steps taken are logical and could drive acceleration from what appears to be the bottom," the analyst tells investors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DOCU: